Drug Shortage Report for RATIO-IPRA SAL UDV
| Report ID | 88167 |
| Drug Identification Number | 02243789 |
| Brand name | RATIO-IPRA SAL UDV |
| Common or Proper name | IPRATROPIUM SALBUTAMOL |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | IPRATROPIUM BROMIDE SALBUTAMOL |
| Strength(s) | 0.5MG 2.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION |
| Packaging size | 20x2.5ML |
| ATC code | R03AL |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-07-02 |
| Estimated end date | 2019-07-30 |
| Actual end date | 2019-07-15 |
| Shortage status | Resolved |
| Updated date | 2019-07-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-07-16 | English | Compare |
| v6 | 2019-07-15 | French | Compare |
| v5 | 2019-07-15 | English | Compare |
| v4 | 2019-07-03 | English | Compare |
| v3 | 2019-07-02 | French | Compare |
| v2 | 2019-07-02 | English | Compare |
| v1 | 2019-07-02 | English | Compare |
Showing 1 to 7 of 7